<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Kite Pharma — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/kite-pharma</link>
    <description>Plain-English explanations of patents assigned to Kite Pharma, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Sep 2026 23:40:44 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/kite-pharma/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Treating a Specific Lymphoma with Modified T Cells</title>
      <link>https://patentbrief.org/patent/us/12600775/chimeric-antigen-receptor-t-cell-therapy</link>
      <description>This patent describes a method to treat a difficult-to-treat type of lymphoma by taking a patient&apos;s own immune cells, modifying them to recognize and attack cancer, and then giving them back to the patient.</description>
      <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/12600775/chimeric-antigen-receptor-t-cell-therapy</guid>
    </item>
  </channel>
</rss>
